Recent advances in the treatment of arrhythmias

Circulation Journal

Volumn 67, Issue 8, 2003, Pages 651-655

  Grant, Augustus O ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Atrial fibrillation; Catheter ablation; Implantable cardioverter defibrillator

Indexed keywords

ANTICOAGULANT AGENT;

CATHETER ABLATION; DEFIBRILLATOR; ENERGY RESOURCE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; LONG TERM CARE; PATIENT MONITORING; PRIMARY PREVENTION; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

EID: 0043095360     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.651     Document Type: Review

References (23)

1. AFFIRM. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833.
2. AFFIRM. Atrial Fibrillation Follow-Up Investigation of Rhythm Management: The AFFIRM Study Design. Am J Cardiol 1997; 79: 1198-1202.
3. Calkins H, Epstein A, Packer D, Arria AM, Hummel J, Gilligan DM, et al. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy. J Am Coll Cardiol 2000; 35: 1905-1914.
4. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm. Circulation 1990; 82: 1106-1116.
5. Darbar D, Olgin J, Miller J, Friedman PA. Localization of the origin of arrhythmias for ablation: From electrocardiography to advanced endocardial mapping systems. J Cardiovasc Electrophysiol 2001; 12: 1309-1325.
6. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375.
7. Haines DE. Catheter ablation therapy for arrhythmias. Philadelphia, PA: Lippincott Williams & Wilkins, 2002.
8. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 2000; 339: 659-666.
9. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Electrophysiological end point for catheter ablation of atrial fibrillation iniitated from multiple pulmonary venous foci. Circulation 2000; 101: 1409-1417.
10. Hoffmann E, Nimmermann P, Reithmann C, Elser F, Remp T, Steinbeck G. New mapping technology for atrial tachycardias. J Intervent Card Electrophysiol 2000; 4: 117-120.
11. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001; 345: 1473-1482.
12. Jais P, Shah DC, Haissaguerre M, Hocini M, Garrigue S, Clementy J. Atrial fibrillation: Role of arrhythmogenic foci. J Interv Card Electrophysiol 2000; 4: 29-37.
13. Jais P, Weerasooriya R, Shah DC, Hocini M, Macle L, Choi K-J, et al. Ablation therapy for atrial fibrillation (AF): Past, present and future. Cardiovasc Res 2002; 54: 337-346.
14. Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 2000; 101: 1288-1296.
15. Mirza I, James S, Holt P. Biatrial pacing for paroxysmal atrial fibrillation: Randomized prospective study into the suppression of paroxysmal atrial fibrillation using biatrial pacing. J Am Coll Cardiol 2002; 40: 457-463.
16. Moss AJ, Zareba W, Hall J, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
17. Saksena S, Madan N. Management of the patient with an implantable cardioverter-defibrillator in the third millennium. Circulation 2002; 106: 2642-2646.
18. Saksena S, Prakash A, Ziegler P, Hummel JD, Friedman P, Plumb VJ, et al. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 2002; 40: 1140-1150.
19. Scheinman MM, Morady F. Nonpharmacological approaches to atrial fibrillation. Circulation 2001; 103: 2120-2125.
20. Sosa E, Scanavacca M, d'Avila A. Transthoracic epicardial catheter ablation to treat recurrent ventricular tachycardia. Curr Cardiol Rep 2001; 3: 451-458.
21. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, et al. A comparision of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347: 1834-1840.
22. Williams MR, Stewart JR, Bolling SF, Freeman S, Anderson JT, Argenziano M, et al. Surgical treatment of atrial fibrillation using radiofrequency energy. Ann Thorac Surg 2001; 71: 1939-1944.
23. Zipes DP. Implantable cardioverter-defibrillator: A Volkswagen or a Rolls Royce: How much will we pay to save a life? Circulation 2001: 103: 1372-1374.